Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer

Published:2016-04-25 Issue:1 Volume:157 Page:55-63
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Tabuchi Yukiko,Shimoda Masafumi,Kagara Naofumi,Naoi Yasuto,Tanei Tomonori,Shimomura Atsushi,Shimazu Kenzo,Kim Seung Jin,Noguchi Shinzaburo

Funder

AstraZeneca

Novartis Pharma

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-016-3801-4.pdf

Reference29 articles.

1. Parmiani G, De Filippo A, Novellino L, Castelli C (2007) Unique human tumor antigens: immunobiology and use in clinical trials. J Immunol 178:1975–1979

2. Finn O (2008) Cancer immunology. N Engl J Med 358:2704–2715

3. Lu H, Goodell V, Disis ML (2008) Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer. J Proteome Res 7:1388–1394

4. Chapman C, Murray A, Chakrabarti J et al (2007) Autoantibodies in breast cancer: their use as an aid to early diagnosis. Ann Oncol 18:868–873

5. Graus F, Dalmou J, Rene R et al (1997) Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival. J Clin Oncol 15:2866–2872

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibodies in cancer: a systematic review of their clinical role in the most prevalent cancers;Frontiers in Immunology;2024-08-21

2. Predictability of B cell clonal persistence and immunosurveillance in breast cancer;Nature Immunology;2024-05

3. Clinical Significance of Uncommon, Non-Clinical, and Novel Autoantibodies;ImmunoTargets and Therapy;2024-04

4. B cell clonality in cancer;Seminars in Immunology;2024-03

5. Autoantibodies of inflammatory cytokines as serum biomarkers in OSA patients;Clinica Chimica Acta;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3